Accelerate Diagnostics
AXDX
#9649
Rank
โ‚น2.44 B
Marketcap
โ‚น97.63
Share price
-4.17%
Change (1 day)
-73.99%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น6.85 Billion

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are โ‚น6.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น7.22 B-17.85%
2021-12-31โ‚น8.79 B-23.06%
2020-12-31โ‚น11.42 B13%
2019-12-31โ‚น10.11 B13.08%
2018-12-31โ‚น8.94 B1957.16%
2017-12-31โ‚น0.43 B27.02%
2016-12-31โ‚น0.34 B-18.34%
2015-12-31โ‚น0.41 B73.55%
2014-12-31โ‚น0.24 B104.21%
2013-12-31โ‚น0.11 B
2012-07-31โ‚น0.13 B105.77%
2011-07-31โ‚น64.05 M1.61%
2010-07-31โ‚น63.03 M-1%
2009-07-31โ‚น63.67 M6.08%
2008-07-31โ‚น60.02 M18.12%
2007-07-31โ‚น50.81 M-1.28%
2006-07-31โ‚น51.47 M-11.43%
2005-07-31โ‚น58.11 M26.94%
2004-07-31โ‚น45.78 M-2.27%
2003-07-31โ‚น46.84 M-24.8%
2002-07-31โ‚น62.29 M17.95%
2001-07-31โ‚น52.81 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น4.351 T 63,349.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น560.65 B 8,074.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.665 T 38,759.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น264.49 B 3,756.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น27.61 B 302.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น362.47 B 5,184.67%๐Ÿ‡บ๐Ÿ‡ธ USA